nifedipine has been researched along with Insulin Resistance in 14 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to evaluate the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus." | 9.20 | Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus. ( D'Angelo, A; Dario Ragonesi, P; Derosa, G; Franzetti, I; Maffioli, P; Querci, F, 2015) |
| "We evaluated insulin sensitivity in two groups of essential hypertensive subjects before and after treatment with either long-acting nifedipine (nifedipine-CR, Adalat CR tablets; Bayer Yakuhin, Osaka, Japan) (n = 10) or metoprolol (n = 9)." | 9.10 | Improvement of insulin sensitivity by a long-acting nifedipine preparation (nifedipine-CR) in patients with essential hypertension. ( Harano, Y; Kodama, K; Koyama, Y; Suzuki, M, 2002) |
| "The aim of this study was to evaluate the effect of trandolapril, an angiotensin converting enzyme inhibitor, on blood pressure, forearm blood flow and insulin sensitivity in comparison with nifedipine gastrointestinal therapeutic system." | 9.09 | Controlled study of the effect of angiotensin converting enzyme inhibition versus calcium-entry blockade on insulin sensitivity in overweight hypertensive patients: Trandolapril Italian Study (TRIS). ( Capaldo, B; Carretta, R; Fabris, F; Ferrara, LA; Galletti, F; Glorioso, N; Mancini, M; Semplicini, A; Strazzullo, P, 1999) |
| "To investigate the effect of amlodipine, nifedipine and perindopril on insulin sensitivity(IS) and blood lipid of patients with essential hypertension(EH)." | 9.08 | [The effect of amlodipine, nifedipine and perindopril on insulin sensitivity and blood lipid of patients with essential hypertension]. ( Chen, D; Lin, J; Wu, K, 1998) |
| "To assess the effects of a vasodilatory beta-adrenoceptor blocker, nipradilol, and a long-acting Ca channel blocker, barnidipine, on insulin sensitivity." | 7.70 | Effect of the vasodilatory beta-blocker, nipradilol, and Ca-antagonist, barnidipine, on insulin sensitivity in patients with essential hypertension. ( Awata, T; Inaba, M; Katayama, S; Kosegawa, I; Morita, T, 1998) |
| "The improvement in postprandial lipidemia by nifedipine may add to its anti-atherogenic effects in hypertensive patients." | 6.82 | Nifedipine Treatment for Hypertension is Associated with Enhanced Lipolytic Activity and Accelerated Clearance of Postprandial Lipemia. ( Charach, G; Grosskopf, I; Harats, D; Kamari, Y; Shaish, A, 2016) |
| "Nifedipine-treated obese males showed a mild but significant decrease in weight gain that was due to a decrease in fat deposition in both subcutaneous and abdominal depots and systolic blood pressure was significantly reduced after one month of treatment." | 5.29 | Treatment of obese female and male SHHF/Mcc-fa(cp) rats with antihypertensive drugs, nifedipine and enalapril: effects on body weight, fat distribution, insulin resistance and systolic pressure. ( Chu, YY; Hoepf, TM; McCune, SA; Radin, MJ, 1993) |
| "The aim of this study was to evaluate the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus." | 5.20 | Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus. ( D'Angelo, A; Dario Ragonesi, P; Derosa, G; Franzetti, I; Maffioli, P; Querci, F, 2015) |
| "We evaluated insulin sensitivity in two groups of essential hypertensive subjects before and after treatment with either long-acting nifedipine (nifedipine-CR, Adalat CR tablets; Bayer Yakuhin, Osaka, Japan) (n = 10) or metoprolol (n = 9)." | 5.10 | Improvement of insulin sensitivity by a long-acting nifedipine preparation (nifedipine-CR) in patients with essential hypertension. ( Harano, Y; Kodama, K; Koyama, Y; Suzuki, M, 2002) |
| "The aim of this study was to evaluate the effect of trandolapril, an angiotensin converting enzyme inhibitor, on blood pressure, forearm blood flow and insulin sensitivity in comparison with nifedipine gastrointestinal therapeutic system." | 5.09 | Controlled study of the effect of angiotensin converting enzyme inhibition versus calcium-entry blockade on insulin sensitivity in overweight hypertensive patients: Trandolapril Italian Study (TRIS). ( Capaldo, B; Carretta, R; Fabris, F; Ferrara, LA; Galletti, F; Glorioso, N; Mancini, M; Semplicini, A; Strazzullo, P, 1999) |
| "To investigate the effect of amlodipine, nifedipine and perindopril on insulin sensitivity(IS) and blood lipid of patients with essential hypertension(EH)." | 5.08 | [The effect of amlodipine, nifedipine and perindopril on insulin sensitivity and blood lipid of patients with essential hypertension]. ( Chen, D; Lin, J; Wu, K, 1998) |
| "These results suggest that nifedipine can enhance insulin sensitivity and reduce white adipose tissue, possibly related to stimulation of adipocyte differentiation." | 3.77 | Nifedipine, a calcium-channel blocker, attenuated glucose intolerance and white adipose tissue dysfunction in type 2 diabetic KK-A(y) mice. ( Horiuchi, M; Inaba, S; Iwai, M; Kanno, H; Nakaoka, H; Senba, I; Sone, H, 2011) |
| "To assess the effects of a vasodilatory beta-adrenoceptor blocker, nipradilol, and a long-acting Ca channel blocker, barnidipine, on insulin sensitivity." | 3.70 | Effect of the vasodilatory beta-blocker, nipradilol, and Ca-antagonist, barnidipine, on insulin sensitivity in patients with essential hypertension. ( Awata, T; Inaba, M; Katayama, S; Kosegawa, I; Morita, T, 1998) |
| "The improvement in postprandial lipidemia by nifedipine may add to its anti-atherogenic effects in hypertensive patients." | 2.82 | Nifedipine Treatment for Hypertension is Associated with Enhanced Lipolytic Activity and Accelerated Clearance of Postprandial Lipemia. ( Charach, G; Grosskopf, I; Harats, D; Kamari, Y; Shaish, A, 2016) |
| "Nifedipine-treated obese males showed a mild but significant decrease in weight gain that was due to a decrease in fat deposition in both subcutaneous and abdominal depots and systolic blood pressure was significantly reduced after one month of treatment." | 1.29 | Treatment of obese female and male SHHF/Mcc-fa(cp) rats with antihypertensive drugs, nifedipine and enalapril: effects on body weight, fat distribution, insulin resistance and systolic pressure. ( Chu, YY; Hoepf, TM; McCune, SA; Radin, MJ, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, S | 1 |
| Han, D | 1 |
| Kang, HG | 1 |
| Jeong, SJ | 1 |
| Jo, JE | 1 |
| Shin, J | 1 |
| Kim, DK | 1 |
| Park, HW | 1 |
| Derosa, G | 1 |
| Querci, F | 1 |
| Franzetti, I | 1 |
| Dario Ragonesi, P | 1 |
| D'Angelo, A | 1 |
| Maffioli, P | 1 |
| Cicero, AF | 1 |
| Tocci, G | 1 |
| Grosskopf, I | 1 |
| Shaish, A | 1 |
| Charach, G | 1 |
| Harats, D | 1 |
| Kamari, Y | 1 |
| Iwai, M | 1 |
| Kanno, H | 1 |
| Inaba, S | 1 |
| Senba, I | 1 |
| Sone, H | 1 |
| Nakaoka, H | 1 |
| Horiuchi, M | 1 |
| Koyama, Y | 1 |
| Kodama, K | 1 |
| Suzuki, M | 1 |
| Harano, Y | 1 |
| Yoshida, D | 1 |
| Higashiura, K | 1 |
| Shimamoto, K | 1 |
| Radin, MJ | 1 |
| Chu, YY | 1 |
| Hoepf, TM | 1 |
| McCune, SA | 1 |
| Francini, F | 1 |
| Gagliardino, JJ | 1 |
| Borelli, MI | 1 |
| Kosegawa, I | 1 |
| Inaba, M | 1 |
| Morita, T | 1 |
| Awata, T | 1 |
| Katayama, S | 1 |
| Galletti, F | 1 |
| Strazzullo, P | 1 |
| Capaldo, B | 1 |
| Carretta, R | 1 |
| Fabris, F | 1 |
| Ferrara, LA | 1 |
| Glorioso, N | 1 |
| Semplicini, A | 1 |
| Mancini, M | 1 |
| Lin, J | 1 |
| Chen, D | 1 |
| Wu, K | 1 |
| Dimo, T | 1 |
| Rakotonirina, A | 1 |
| Tan, PV | 1 |
| Dongo, E | 1 |
| Dongmo, AB | 1 |
| Kamtchouing, P | 1 |
| Azay, J | 1 |
| Abegaz, BM | 1 |
| Cros, G | 1 |
| Ngadjui, TB | 1 |
| Eckel, J | 1 |
| Asskamp, B | 1 |
| Reinauer, H | 1 |
1 review available for nifedipine and Insulin Resistance
| Article | Year |
|---|---|
[Treatment of hypertensive patients with impaired glucose tolerance (IGT)].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive | 2005 |
5 trials available for nifedipine and Insulin Resistance
| Article | Year |
|---|---|
Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus.
Topics: Adipokines; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; | 2015 |
Nifedipine Treatment for Hypertension is Associated with Enhanced Lipolytic Activity and Accelerated Clearance of Postprandial Lipemia.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Female; Humans; Hyperlipidemias; Hypertension; | 2016 |
Improvement of insulin sensitivity by a long-acting nifedipine preparation (nifedipine-CR) in patients with essential hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Area Under Curve; Blood Glucose; Calcium Channel Blockers; Delaye | 2002 |
Controlled study of the effect of angiotensin converting enzyme inhibition versus calcium-entry blockade on insulin sensitivity in overweight hypertensive patients: Trandolapril Italian Study (TRIS).
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Blood Pressure; Calcium; | 1999 |
[The effect of amlodipine, nifedipine and perindopril on insulin sensitivity and blood lipid of patients with essential hypertension].
Topics: Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Female; Humans; Hypertension; Insulin | 1998 |
8 other studies available for nifedipine and Insulin Resistance
| Article | Year |
|---|---|
Intravenous sustained-release nifedipine ameliorates nonalcoholic fatty liver disease by restoring autophagic clearance.
Topics: Administration, Intravenous; Animals; Autophagy; Calcium Channel Blockers; Delayed-Action Preparatio | 2019 |
Metabolic approaches to antihypertensive treatment in diabetic patients.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Calcium | 2015 |
Nifedipine, a calcium-channel blocker, attenuated glucose intolerance and white adipose tissue dysfunction in type 2 diabetic KK-A(y) mice.
Topics: Adipocytes; Adipogenesis; Adiponectin; Adipose Tissue, White; Animals; Blood Glucose; Calcium Channe | 2011 |
Treatment of obese female and male SHHF/Mcc-fa(cp) rats with antihypertensive drugs, nifedipine and enalapril: effects on body weight, fat distribution, insulin resistance and systolic pressure.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Body Composition; Body Constitution; Body Weight; | 1993 |
Decreased islet sensitivity to insulin in hamsters with dietary-induced insulin resistance.
Topics: Androstadienes; Animals; Body Water; Body Weight; Calcium Channel Blockers; Carbon Dioxide; Cricetin | 2008 |
Effect of the vasodilatory beta-blocker, nipradilol, and Ca-antagonist, barnidipine, on insulin sensitivity in patients with essential hypertension.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Calcium Channel Blockers; Female; Glucose Clamp Techniq | 1998 |
Antihypertensive effects of Dorstenia psilurus extract in fructose-fed hyperinsulinemic, hypertensive rats.
Topics: Africa; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Cholesterol; Creatinine; Di | 2001 |
Induction of insulin resistance in primary cultured adult cardiac myocytes.
Topics: Animals; Biological Transport; Bucladesine; Cells, Cultured; Cyclic AMP; Cycloheximide; Cytochalasin | 1991 |